Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 21Rectal Neoplasms 10Colonic Neoplasms 6Pancreatic Neoplasms 4Stomach Neoplasms 3Neoplasm Metastasis 3Adenocarcinoma Of Esophagus 3Peritoneal Neoplasms 2Neoplasms 2Liver Neoplasms 2Esophageal Neoplasms 2Pancreatic Adenocarcinoma 1Ovarian Neoplasms 1Neuropathy, Painful 1Neuralgia 1Neoplasm Recurrence, Local 1Malignant Solid Tumour 1Locally Advanced Pancreatic Carcinoma(LAPC) 1Gallbladder Neoplasms 1Esophageal Squamous Cell Carcinoma 1Disease Progression 1Cold Hypersensitivity 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Carcinoma, Basal Cell 1Breast Neoplasms 1Bile Duct Neoplasms 1Advanced Rectal Cancer 1Advanced Primary Liver Cancer 1Adenocarcinoma of the Lower Rectum 1

Interventions

Radiotherapy 11Cisplatin 10Paclitaxel 9pembrolizumab 7Fluorouracil 7Oxaliplatin 6Irinotecan 6tislelizumab 5Cetuximab 5Docetaxel 4Radiation 3Nivolumab 3Leucovorin 3Carboplatin 3Capecitabine 3Neoadjuvant Therapy 2Immunohistochemistry 2Biopsy 210-propargyl-10-deazaaminopterin 2tremelimumab 1sitravatinib 1sintilimab 1regorafenib 1pegylated granulocyte colony-stimulating factor, human 1pegfilgrastim 1oblimersen 1durvalumab 1cixutumumab 1adavosertib 1Taxes 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Esophageal Squamous Cell Carcinoma × Folfox protocol × Clear all
NCT00381706 2021-09-29

Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Completed
245 enrolled 15 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡